title: Diagnosis and management of hyponatremia in cancer patients.
abstract: BACKGROUND
  Hyponatremia is among the metabolic disturbances encountered in oncology. Risk factors for hyponatremia include chemotherapy, treatment-induced nausea and vomiting, hydration, pain, narcotic drugs, and physical and emotional stress. A common cause of hyponatremia in patients with cancer is the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), which may result from ectopic production of arginine vasopressin (AVP) by the tumor tissue.
  
  
  METHODS
  The AVP-receptor antagonists, a new class of agents, correct hyponatremia by directly blocking the binding of AVP with its receptors. In clinical trials, conivaptan, lixivaptan, tolvaptan, and satavaptan have increased serum osmolality and normalized the serum [Na(+)] in hyponatremia associated with SIADH, cirrhosis, or congestive heart failure. These drugs may have a potential in cancer-related hyponatremia as well.
authors: Columbia University, New York, NY 10032, USA. hr43@columbia.edu
authors: Harry
authors: H
authors: Raftopoulos
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin; D006801:Humans; D007010:Hyponatremia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D007177:Inappropriate ADH Syndrome; D009369:Neoplasms / Q000150:complications* / Q000503:physiopathology; D012307:Risk Factors
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin
references: Ann Oncol. 2000 Aug;11(8):1061-5
references: 11038047
references: Gastroenterology. 2003 Apr;124(4):933-9
references: 12671890
references: Hepatology. 2003 Jan;37(1):182-91
references: 12500203
references: Semin Oncol. 1989 Dec;16(6):504-15
references: 2688110
references: Baillieres Clin Endocrinol Metab. 1989 Aug;3(2):313-30
references: 2698140
references: Am J Clin Oncol. 2002 Aug;25(4):344-6
references: 12151962
references: J Mol Endocrinol. 2002 Aug;29(1):1-9
references: 12200224
references: Am J Med Sci. 2003 Jul;326(1):25-30
references: 12861122
references: Annu Rev Med. 1993;44:289-301
references: 8476251
references: Pediatr Clin North Am. 1990 Apr;37(2):351-63
references: 2184401
references: Am Fam Physician. 2004 May 15;69(10):2387-94
references: 15168958
references: QJM. 1995 Dec;88(12):905-9
references: 8593551
references: CA Cancer J Clin. 1987 Sep-Oct;37(5):302-20
references: 3115508
references: Clin J Oncol Nurs. 2003 Jul-Aug;7(4):425-30
references: 12929276
references: Am J Med. 2006 Jan;119(1):71.e1-8
references: 16431193
references: Int J Biochem Cell Biol. 2003 Nov;35(11):1495-9
references: 12824060
references: Jpn J Clin Oncol. 2001 Aug;31(8):382-7
references: 11574631
references: Acta Oncol. 1995;34(2):264-5
references: 7718269
references: Clin J Am Soc Nephrol. 2006 Nov;1(6):1154-60
references: 17699341
references: Support Care Cancer. 2000 May;8(3):192-7
references: 10789959
references: Acta Oncol. 1989;28(6):823
references: 2611035
references: Clin Lung Cancer. 2003 Nov;5(3):187-9
references: 14667276
references: Clin Pharm. 1987 Aug;6(8):625-33
references: 3121240
references: Support Care Cancer. 1996 Sep;4(5):341-50
references: 8883227
references: BJU Int. 2002 Dec;90 Suppl 3:1-6
references: 12445090
references: JAMA. 2004 Apr 28;291(16):1963-71
references: 15113814
references: Am J Med. 1967 May;42(5):790-806
references: 5337379
references: Ann Intern Med. 1985 Feb;102(2):164-8
references: 3966753
references: Med Clin North Am. 1997 May;81(3):585-609
references: 9167647
references: Endocrinol Metab Clin North Am. 2001 Sep;30(3):671-94, vii
references: 11571936
references: J Clin Endocrinol Metab. 2006 Jun;91(6):2145-52
references: 16522696
references: Am J Nephrol. 1996;16(4):349-51
references: 8739291
references: Oncol Nurs Forum. 1989 May-Jun;16(3):373-81
references: 2660120
references: Am J Med. 1957 Oct;23(4):529-42
references: 13469824
references: Am J Nephrol. 2007;27(5):447-57
references: 17664863
references: J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S10-4
references: 11251026
references: Cancer Res. 1993 Jan 1;53(1):67-74
references: 8380126
references: J Clin Oncol. 1986 Aug;4(8):1191-8
references: 3016206
references: Circulation. 2003 Jun 3;107(21):2690-6
references: 12742979
references: Lung Cancer. 1994 Mar;10 Suppl 1:S97-103
references: 8087532
references: J Intern Med. 1995 Aug;238(2):97-110
references: 7629492
references: Br J Cancer. 1993 Oct;68(4):767-74
references: 8398705
references: Trends Endocrinol Metab. 2003 May-Jun;14(4):182-7
references: 12714279
references: Cancer. 1980 May 1;45(9):2414-21
references: 7379038
references: Cancer. 1995 May 15;75(10):2442-51
references: 7736387
references: N Engl J Med. 2000 May 25;342(21):1581-9
references: 10824078
references: J Natl Cancer Inst. 1990 Feb 21;82(4):305-10
references: 2153841
references: N Engl J Med. 2006 Nov 16;355(20):2099-112
references: 17105757